1 - 6 out of 6Page size: 10
  1. 2023

  2. Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV

    Verburgh, M. L., van Pul, L., Grobben, M., Boyd, A., Wit, F. W. N. M., van Nuenen, A. C., van Dort, K. A., Tejjani, K., van Rijswijk, J., Bakker, M., van der Hoek, L., Schim van der Loeff, M. F., van der Valk, M., van Gils, M. J., Kootstra, N. A. & Reiss, P., 11 May 2023, (E-pub ahead of print) In: Microbiology spectrum. p. e0115523

    Research output: Contribution to journal › Article › Academic › peer-review

  3. 2022

  4. Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection

    Lavell, A. H. A., Sikkens, J. J., Edridge, A. W. D., van der Straten, K., Sechan, F., Oomen, M., Buis, D. T. P., Schinkel, M., Burger, J. A., Poniman, M., van Rijswijk, J., de Jong, M. D., de Bree, G. J., Peters, E. J. G., Smulders, Y. M., Sanders, R. W., van Gils, M. J., van der Hoek, L. & Bomers, M. K., 21 Oct 2022, In: iScience. 25, 10, 105105.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Older people with well-controlled HIV have similar antibody and higher T-cell responses after vaccination against SARS-CoV-2 compared to demographically and lifestyle-comparable people without HIV

    Verburgh, M., van Pul, L., Grobben, M., Boyd, A., Wit, F., van Nuenen, A., van Dort, K., Tejjani, K., van Rijswijk, J., Bakker, M., van der Hoek, L., van der Loeff, M. S., van der Valk, M., van Gils, M., Kootstra, N. & Reiss, P., 1 Oct 2022, In: Journal of the International AIDS Society. 25, 6, SI, p. 7-9 3 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron

    van der Straten, K., Guerra, D., van Gils, M. J., Bontjer, I., Caniels, T. G., van Willigen, H. D. G., Wynberg, E., Poniman, M., Burger, J. A., Bouhuijs, J. H., van Rijswijk, J., Olijhoek, W., Liesdek, M. H., Lavell, A. H. A., Appelman, B., Sikkens, J. J., Bomers, M. K., Han, A. X., Nichols, B. E., Prins, M., & 7 othersVennema, H., Reusken, C., de Jong, M. D., de Bree, G. J., Russell, C. A., Eggink, D. & Sanders, R. W., 13 Sept 2022, In: Immunity. 55, 9, p. 1725-1731.e4

    Research output: Contribution to journal › Article › Academic › peer-review

  7. Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children

    Keuning, M. W., Grobben, M., Bijlsma, M. W., Anker, B., Berman-de Jong, E. P., Cohen, S., Felderhof, M., de Groen, A-E., de Groof, F., Rijpert, M., van Eijk, H. W. M., Tejjani, K., van Rijswijk, J., Steenhuis, M., Rispens, T., Plötz, F. B., van Gils, M. J. & Pajkrt, D., 9 Sept 2022, In: Frontiers in immunology. 13, 976382.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study

    van Gils, M. J., Lavell, A., van der Straten, K., Appelman, B., Bontjer, I., Poniman, M., Burger, J. A., Oomen, M., Bouhuijs, J. H., van Vught, L. A., Slim, M. A., Schinkel, M., Wynberg, E., van Willigen, H. D. G., Grobben, M., Tejjani, K., van Rijswijk, J., Snitselaar, J. L., Caniels, T. G., Vlaar, A. P. J., & 6 othersPrins, M., de Jong, M. D., de Bree, G. J., Sikkens, J. J., Bomers, M. K. & Sanders, R. W., 1 May 2022, In: PLoS medicine. 19, 5, e1003991.

    Research output: Contribution to journal › Article › Academic › peer-review

ID: 12611156